Latest Breaking News On - South east sydney health - Page 1 : comparemela.com

Surmodics, Inc : Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

Surmodics, Inc : Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEden prairieNew yorkNew zealandNew south walesRamon varcoeSurmodic sundance sirolimusJack powellInternational symposium on endovascular therapySurmodics incSurmodic sundance sirolimus drug coatedProfessor ramon varcoeSundance sirolimus drug coated balloonYear results with the sundanceFrom theNew york hilton midtown

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

35-subject SWING Trial evaluates the safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated Balloon Updated safety and performance data for the SWING trial 24-month data will be.

United statesNew zealandNew south walesNew yorkEden prairieRamon varcoeSurmodics incInternational symposium on endovascular therapyProfessor ramon varcoeSirolimus drug coated balloonYear results with the sundanceFrom theNew york hilton midtownGrand ballroom eastWales hospitalOperating theatres

Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18

16.01.2023 - Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that Professor Ramon Varcoe will present 12-month data from the SWING Trial, a first-in-human study . Seite 1

New zealandMiami beachNew south walesAndrew holdenLoews miami beach hotelWales hospitalOperating theatresSouth east sydney healthNorthern region interventional radiology serviceAuckland city hospitalAnnual symposiumEndovascular issuesSundance sirolimus drug coated balloon

6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe

35-subject trial evaluating safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated BalloonEDEN PRAIRIE, Minn. (BUSINESS WIRE) #Acquisition Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that Professor.

New zealandEden prairieUnited statesNew south walesRamon varcoeSurmodic sundanceAndrew holdenSurmodics incSirolimus drug coatedProfessor ramon varcoeAmputation prevention symposiumMain hallWales hospitalOperating theatresSouth east sydney healthNorthern region interventional radiology service

6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe

6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandEden prairieUnited statesNew south walesRamon varcoeSurmodic sundanceAndrew holdenTim arensSurmodics incSirolimus drug coatedProfessor ramon varcoeAmputation prevention symposiumMain hallWales hospitalOperating theatresSouth east sydney health